Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase.
about
Nitric oxide and boneFrom estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosisNecessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility.HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage.AMPK activation--protean potential for boosting healthspan.Increasing dietary nitrate has no effect on cancellous bone loss or fecal microbiome in ovariectomized rats.Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway.Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.Soluble guanylate cyclase as a novel treatment target for osteoporosis.Epigenetic regulation during fetal femur development: DNA methylation matters.Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female miceInhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling.Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts.Impaired prenylation of Rab GTPases in the gunmetal mouse causes defects in bone cell function.S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesisPro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and IIOxidative stress and heme oxygenase-1 regulated human mesenchymal stem cells differentiationBlood and interstitial flow in the hierarchical pore space architecture of bone tissueA crucial role for thiol antioxidants in estrogen-deficiency bone loss.Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies.Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitroArterial calcification and bone physiology: role of the bone-vascular axis.Molecular pathways mediating mechanical signaling in bone.Cardiovascular disease and osteoporosis: balancing risk management.Role of Epithelium Sodium Channel in Bone Formation.Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.Organic nitrates for osteoporosis: an update.Calcium signalling and calcium transport in bone disease.Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction.Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal womenTransdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.Therapeutic perspectives.Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling.Osteogenic growth peptide and its use as a bio-conjugate in regenerative medicine applications.Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression.
P2860
Q28343869-FF517E7D-15FD-4B9D-B96D-1845B49AA818Q28385120-93451F22-0247-490B-A328-AD747513899CQ30497308-89F4FF58-47B9-41FC-906D-178A950E6C27Q33637974-7CF8A80D-1815-42E7-B162-1C9B221DD657Q33689169-535FEB72-DEC5-47D2-939C-8BAF820410A5Q33698150-5600BCDD-DAE1-4534-BE9C-259F2EA961FAQ33773854-D41B5A98-CE43-4838-8EA9-F98525DFE07DQ34520133-0DCE923E-E9D5-40E7-8920-345558BFFD73Q34551704-686FB81A-FA65-4F1B-A3B8-FA6A0EB89A51Q34575845-ACEC89CB-E08D-4DC6-9C44-0B86455D6557Q34623111-95B06467-C307-4CCB-8A4C-F6466456BFC5Q34662369-4DBCA583-17CF-41B5-AAEF-F83D3ACFC247Q34775933-8CDD49F5-3EAD-4E25-9700-E39EC37CCA7EQ34977213-49720198-12FE-464E-9496-1785B5588A37Q35107102-587A4E80-535B-49F9-825D-0353A27E527FQ35408904-9015830B-23C4-437C-B23B-810E59173AADQ35668850-0EA62ECD-7F9D-48EF-A315-8A8DFED9F71BQ35810921-358FAABA-636C-4197-9048-40B2E0070BC5Q35811039-6D0CCC93-5AB1-42C8-968C-3CD8B1F651A7Q35919837-CCE4987A-4F98-4911-874F-6C6B343405F7Q36060627-F86E5E55-C4E1-4B2C-89FB-DBBEA55115FEQ36162995-89396FB5-A45D-4C9D-95E3-529D03F898B7Q36176547-458EEF14-426A-48B7-9DEB-47CE724BC8CAQ36177303-97186BF2-EFC3-4EBA-BB55-BC76FE3BF77DQ36345286-37B28C57-C0D2-455D-B146-97B16F0214CBQ36536188-E3F9F921-3EB8-4B84-A1A3-12A99D3C87F3Q36720098-CB9E1DC6-43F4-46A5-B1FD-DA55FD75B561Q36734567-C0CDBE28-12AD-4D1C-A98B-F535A51132FDQ37043897-BB97E19E-E46C-44FD-8A75-55FDFE141014Q37056471-F821D3AA-995C-4E6C-B01E-A1CD484E8542Q37177999-45D246BE-C64C-4735-8093-951C7680D800Q37200844-849DE3D4-A2D1-486D-B07E-7779AADCA012Q37294248-75D02952-CF48-4495-93B1-24F9D582A3AEQ37341848-55901360-F092-4906-931F-B24BCCD42C3FQ37358034-04434195-0C5D-4B4B-BA47-9394A2CF3B33Q37430318-2BBC4D44-F3D0-4E3D-B5DF-440EA7E0E9CEQ37481098-7B6CAB1E-224F-4688-9976-45611C8BAEFFQ38590564-15CB87B8-8544-4E09-BBA4-5272FD9FEF95Q38621537-26CF2951-8139-45C7-92D1-32F0728B695EQ39918764-4A4EA649-97A3-4841-A871-8499411C2953
P2860
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Defective bone formation and a ...... thelial nitric oxide synthase.
@ast
Defective bone formation and a ...... thelial nitric oxide synthase.
@en
type
label
Defective bone formation and a ...... thelial nitric oxide synthase.
@ast
Defective bone formation and a ...... thelial nitric oxide synthase.
@en
prefLabel
Defective bone formation and a ...... thelial nitric oxide synthase.
@ast
Defective bone formation and a ...... thelial nitric oxide synthase.
@en
P2093
P356
P1433
P1476
Defective bone formation and a ...... thelial nitric oxide synthase.
@en
P2093
Gallagher ME
Helfrich MH
Ralston SH
P304
P356
10.1210/ENDO.142.2.7977
P407
P577
2001-02-01T00:00:00Z